National Trends in the Ambulatory Treatment of Hypertension in the United States, 1997-2012

• Meijia Zhou,

  Affiliations Department of Epidemiology, Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Matthew Daubresse,

  Affiliations Department of Epidemiology, Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Randall S. Stafford,

  Affiliation Program on Prevention Outcomes and Practices, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, United States of America

  ⨯
• G. Caleb Alexander

  * E-mail: galexand@jhsph.edu

  Affiliations Department of Epidemiology, Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland, United States of America

  ⨯